Turning Point Benefit Group’s Synovus SNV Stock Holding History

Turning Point Benefit Group’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$350	–	684
2025 Q4	$350	Hold	7	–	–	﹤0.01%	688
2025 Q3	$340	Buy	+7	New	+$359	﹤0.01%	559

Other funds holding SNV

WBWA

William B. Walkup & Associates Columbia, South Carolina $208M AUM 37.34% 1-Year Est. Return

Turning Point Benefit Group's SNV Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Synovus (SNV) in Q1 2026, closing a stake of 7 shares — an estimated $350 sold.

Turning Point Benefit Group first reported a position in SNV in Q3 2025 and held it in 2 quarters. The position peaked at $350 in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

Turning Point Benefit Group reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 7 Synovus shares in Q1 2026, an estimated $350.
Turning Point Benefit Group first reported a position in Synovus in Q3 2025 and held it in 2 quarters.
Turning Point Benefit Group's Synovus position peaked at $350 in Q4 2025.
1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.